With a market capitalization (market cap) of $5.79B — a measure of how much the company is worth — Stevanato Group S.p.A. is the 1318th most valuable company in Healthcare as of August 18, 2026. Shares trade at $21.20, down +0.28% on the day.
of 2,587
price ÷ annual EPS
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
Stevanato Group S.p.A. is dedicated to engineering, manufacturing, and distributing integrated solutions for the pharmaceutical and healthcare sectors. Its core offerings span a wide array of products, including containment solutions, drug delivery systems, and medical devices, alongside diagnostic and analytical support. The company also produces specialized machinery for tasks such as visual inspection, assembly, packaging, and glass formation. Established in 1949, the company's main operations are situated in Piombino Dese, Italy, functioning as a subsidiary of Stevanato Holding S.R.L.
Visit websiteAs of August 18, 2026, Stevanato Group S.p.A. (STVN) is worth $5.79B — this is its market capitalization, the total value of all its outstanding shares.
Stevanato Group S.p.A.’s market cap is $5.79B, which ranks it #1318 among the most valuable companies in the Healthcare sector tracked on MarketCapLens.
Stevanato Group S.p.A. (STVN) shares trade at $21.20, down 0.28% on the day, as of August 18, 2026.
Stevanato Group S.p.A. trades at a price-to-earnings (P/E) ratio of 43.3, based on its latest share price and annual earnings per share.
Fundamentals are annual. Figures labeled with their fiscal year.
FY 2025